NCT00516581

Brief Summary

From the beginning of the AIDS epidemic, pulmonary pneumocystosis (PCP) has been distinguished as one of the most frequent opportunistic diseases with high morbid-mortality. As from 1996, the advent of the highly active antiretroviral therapy (HAART) has changed the characteristics of such epidemic by reducing its related diseases and, as a result, AIDS-related mortality. With the purpose to estimate PCP occurrence and HAART interference, 376 HIV-infected or AIDS patients were studied from January 1992 to December 2002.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
376

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2003

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2003

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2005

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

August 14, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 15, 2007

Completed
Last Updated

September 5, 2008

Status Verified

September 1, 2008

First QC Date

August 14, 2007

Last Update Submit

September 4, 2008

Conditions

Keywords

Pneumocystis PneumoniaAcquired Immune Deficiency SyndromeHighly Active Antiretroviral TherapyTreatment ExperiencedTreatment Naive

Study Arms (2)

no HAART

Patients that no received HAART

with HAART

Patients that received HAART

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

376 HIV-infected or AIDS patients were studied from January 1992 to December 2002

You may qualify if:

  • HIV infection

You may not qualify if:

  • No HIV infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculdade de Medicina de Botucatu - Unesp

Botucatu, São Paulo, 18618970, Brazil

Location

MeSH Terms

Conditions

Pneumonia, PneumocystisAcquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

Lung Diseases, FungalMycosesBacterial Infections and MycosesInfectionsPneumocystis InfectionsRespiratory Tract InfectionsPneumoniaLung DiseasesRespiratory Tract DiseasesHIV InfectionsBlood-Borne InfectionsCommunicable DiseasesSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Alexandre N Barbosa, MD, MSc

    UPECLIN HC FM Botucatu Unesp

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 14, 2007

First Posted

August 15, 2007

Study Start

February 1, 2003

Study Completion

February 1, 2005

Last Updated

September 5, 2008

Record last verified: 2008-09

Locations